E-cigarette battle lines form in federal court

Last week, we highlighted the Oregon attorney general's fight against e-cigarettes, which he considers to be a drug-delivery device being sold to consumers without proper approval from the FDA. The Wall Street Journal points out that the battle goes far beyond Oregon. It is nationwide and just beginning. The industry that markets the battery-powered tubes that turn nicotine-laced liquid into into vapor claims that it is offering products "designed to be recreational alternatives to cigarettes, not devices to wean people off nicotine." If they had to go through clinical trials, they'd be out of business or forced underground. Next week, a federal appellate court hears oral arguments on the question. Report


Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.